Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Jul 18:16:1613147.
doi: 10.3389/fmicb.2025.1613147. eCollection 2025.

Commentary: Role of gut microbiota in infectious and inflammatory diseases

Affiliations
Comment

Commentary: Role of gut microbiota in infectious and inflammatory diseases

Gabriela Angélica Martínez-Nava et al. Front Microbiol. .
No abstract available

Keywords: gout; gut microbiota; hyperuricemia (HUA); inflammation; microbiome and dysbiosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Illustration showing the process of dysbiosis in the gut. Dysbiosis leads to the production of short-chain fatty acids (SCFAs) like acetate, butyrate, and propionate. Acetate crosses the intestinal barrier, influencing naive T-cells and macrophages. Interaction with macrophages through GPR43 and NLRP3 triggers IL-1β production. Naive T-cells differentiate into T-reg or Th17 cells, affecting inflammation. The diagram highlights pathways involving mTOR-S6K, STAT3, and others, leading to the release of cytokines IL-17, IL-21, and IL-26, illustrating inflammatory responses.
Figure 1
Schematic diagram of the microbiota-SCFA-immune axis in gout pathogenesis. Gut dysbiosis leads to altered SCFA production (notably acetate), which acts through GPR43 to promote IL-1β release in macrophages and Th17 differentiation in naïve T cells, fueling joint inflammation.

Comment on

  • Role of gut microbiota in infectious and inflammatory diseases.
    Maciel-Fiuza MF, Muller GC, Campos DMS, do Socorro Silva Costa P, Peruzzo J, Bonamigo RR, Veit T, Vianna FSL. Maciel-Fiuza MF, et al. Front Microbiol. 2023 Mar 27;14:1098386. doi: 10.3389/fmicb.2023.1098386. eCollection 2023. Front Microbiol. 2023. PMID: 37051522 Free PMC article. Review.

References

    1. FitzGerald J. D. (2025). Gout. Ann. Intern. Med. 178, ITC33–ITC48. 10.7326/ANNALS-24-03951 - DOI - PubMed
    1. Guo Z., Zhang J., Wang Z., Ang K. Y., Huang S., Hou Q., et al. (2016). Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep. 6:20602. 10.1038/srep20602 - DOI - PMC - PubMed
    1. Haslberger A., Terkeltaub R. (2015). Editorial: Can GPR43 sensing of short-chain fatty acids unchain inflammasome-driven arthritis? Arthritis Rheumatol. 67, 1419–1423. 10.1002/art.39102 - DOI - PMC - PubMed
    1. Liu X., Lv Q., Ren H., Gao L., Zhao P., Yang X., et al. (2020). The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia. PeerJ. 8:e8664. 10.7717/peerj.8664 - DOI - PMC - PubMed
    1. Liu-Bryan R. (2010). Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome. Immunol. Cell Biol. 88, 20–23. 10.1038/icb.2009.93 - DOI - PMC - PubMed

LinkOut - more resources